DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact

NCT00789477 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

PROCEDURE: Laser Photocoagulation
DRUG: Intravitreal Aflibercept Injection

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]